Home » Stocks » InMode

InMode Ltd. (INMD)

Stock Price: $38.93 USD -0.87 (-2.19%)
Updated Oct 27, 2020 4:00 PM EDT - Market closed
After-hours: $38.55 -0.38 (-0.98%) Oct 27, 6:44 PM

Stock Price Chart

Key Info

Market Cap 1.39B
Revenue (ttm) 158.22M
Net Income (ttm) 50.25M
Shares Out 35.61M
EPS (ttm) 1.16
PE Ratio 33.56
Forward PE 18.80
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 27, 2020
Last Price $38.93
Previous Close $39.80
Change ($) -0.87
Change (%) -2.19%
Day's Open 39.60
Day's Range 38.62 - 39.80
Day's Volume 516,167
52-Week Range 13.14 - 58.76

More Stats

Market Cap 1.39B
Enterprise Value n/a
Earnings Date (est) Nov 12, 2020
Ex-Dividend Date n/a
Shares Outstanding 35.61M
Float 16.26M
EPS (basic) n/a
EPS (diluted) 1.16
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield 2.98%
FCF Yield n/a
Payout Ratio n/a
Shares Short 1.66M
Short Ratio 2.38
Short % of Float 10.20%
Beta n/a
PE Ratio 33.56
Forward PE 18.80
P/FCF Ratio n/a
PS Ratio 8.76
PB Ratio 6.81
Revenue 158.22M
Operating Income n/a
Net Income 50.25M
Free Cash Flow n/a
Net Cash n/a
Net Cash / Share n/a
Gross Margin 86.04%
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA 17.64%
ROE 36.00%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (3)

Buy 2
Overweight 1
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$51.00*
(31.00% upside)
Low
47.0
Current: $38.93
High
55.0
Target: 51.00
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial Overview

No financial data available for this stock yet.

Company Profile

Company Details

Full Name InMode Ltd.
Country Israel
Employees 251
CEO Moshe Mizrahy

Stock Information

Ticker Symbol INMD
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: INMD
IPO Date August 8, 2019

Description

InMode designs, develops, manufactures, and markets minimally-invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radio frequency technologies. The company offers minimally-invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions. InMode Ltd. offers its products directly in the United States, Canada, the United Kingdom, Spain, Australia, and India, as well as indirectly through distributors in 46 countries. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was founded in 2008 and is headquartered in Yokneam, Israel.